(Q42994528)

English

Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response

scientific article published in September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response (English)

1 reference

Europe PubMed Central

12 November 2017

0 references

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

12 November 2017

author name string

T Carlsson

1

1 reference

Europe PubMed Central

12 November 2017

O Reichard

2

1 reference

Europe PubMed Central

12 November 2017

G Norkrans

3

1 reference

Europe PubMed Central

12 November 2017

J Bläckberg

4

1 reference

Europe PubMed Central

12 November 2017

P Sangfelt

5

1 reference

Europe PubMed Central

12 November 2017

E Wallmark

6

1 reference

Europe PubMed Central

12 November 2017

publication date

1 September 2005

1 reference

Europe PubMed Central

12 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

12 November 2017

12

1 reference

Europe PubMed Central

12 November 2017

473-480

1 reference

Europe PubMed Central

12 November 2017

5

1 reference

Europe PubMed Central

12 November 2017

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Viral kinetics and treatment response in patients with hepatitis C during induction and standard interferon therapy in combination with ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Combination of interferon induction therapy and ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Hepatitis C virus resistance to antiviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Histological and virological long-term outcome in patients treated with interferon-alpha2b and ribavirin for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00621.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2005.00621.X

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42994528&oldid=1976274022"